May 2, 2013

IGF-1R targeting increases the antitumor effects of DNA damaging agents in SCLC model: an opportunity to increase the efficacy of standard therapy

IGF-1R targeting increases the antitumor effects of DNA damaging agents in SCLC model: an opportunity to increase the efficacy of standard therapy

IGF-1R targeting increases the antitumor effects of DNA damaging agents in SCLC model: an opportunity to increase the efficacy of standard therapy Charles Ferté, Yohann Loriot, Céline Clémenson, Frederic Commo Andrea Gombos Jean-Emmanuel Bibault, Ingrid Fumagalli, Saad Hamama, Nathalie Auger6, Benoit Lahon, Cyrus Chargari, Julien Calderaro6, Jean-Charles Soria5 and Eric Deutsch. Mol Cancer Ther. 2013 May 2.

SHARE